Normal karyotypes
When the chromosomes look normal and embryos still arrest, the explanation is often functional rather than structural — mitochondrial energy supply, metabolic strain, epigenetic switching, immune signalling, and the timing of genome activation. Those are measurable things, and some of them can be worked on. That is a different question from whether the DNA itself is defective, and it is the question most standard workups never get to.
STRUCTURAL GENETICS
Karyotyping, PGT‑A, classic “chromosome count” problems
FUNCTIONAL GENETICS
Maternal‑to‑embryo genome activation around day 3
Epigenetic switching: methylation, histone changes, RNA processing
Immune and clotting genes that control placental development
Key point: You can have normal chromosomes and still have embryos arrest because the genes never activate properly, or the cell can’t power the work.
Examples:
Chronic high insulin and glucose increase oxidative stress in eggs and sperm
That damages spindles, DNA, and mitochondria, raising the risk of arrest even with normal karyotypes
Clinically, these are often the couples whose embryos stall around day 3–5 while every chromosomal test comes back unremarkable — and whose HbA1c, fasting insulin, triglycerides, and visceral fat have never been reviewed as part of the fertility workup.
Lower progesterone + thyroid issues =
Less stable luteal phase
Reduced progesterone receptor sensitivity in the endometrium
Poorer support for maternal mitochondrial DNA activation and embryonic genome activation around day 3
In plain terms: the embryo has the genes, but the hormonal and mitochondrial context needed to switch them on is weak.
Other metabolic patterns that can look genetic:
Dyslipidemia (high triglycerides, ApoB, VLDL)
Non‑alcoholic fatty liver / elevated GGT
Micronutrient deficits (B vitamins, CoQ10, etc.)
APS / “sticky blood” → micro‑clots in early placental vessels → “genetic” miscarriages
Thyroid antibodies, ANA, other autoimmunity → hostile implantation environment even with normal PGT‑A
Chronic endometritis / pelvic inflammation → altered local cytokines, impaired implantation genes
What This All Means:
These conditions change how genes are expressed and how placental DNA programs run, even when the underlying chromosomes are fine.
Mitochondria are the egg’s battery and the embryo’s engine until after blastocyst
Poor mitochondrial function (from age + metabolic stress) = less ATP, more ROS → developmental arrest and failed maternal DNA activation on day 3
This is why the metabolic and mitochondrial side of a case matters when embryos arrest for no visible reason. The energy available to a developing egg is not set by chromosomes alone, and the inputs that shape it — blood sugar, thyroid function, inflammatory load, sleep, nutrient status — are measurable and can be worked on. Those markers are what we track.
Full karyotype / PGT‑A review, but we don’t stop there
Metabolic panel: HbA1c, insulin curve, lipids, liver, kidney, iron, GGT, etc.
Thyroid panel with antibodies, not just TSH
Immune and clotting screen (APS, inflammation markers)
Uterine environment: endometritis, blood flow, progesterone responsiveness
Male side: DNA fragmentation, oxidative stress, metabolic health
We do not promise pregnancy, and we cannot change your chromosomes. We focus on measurable changes in metabolic, thyroid, inflammatory, and semen markers — and on making sure you have that information before you accept an irreversible decision about your options.
